Evidence map›Paper›PMID 28583112›Full record

Observational studyBMC infectious diseases2017

Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.

S E Salvaggio, A Giacomelli, F S Falvella, M L Oreni, P Meraviglia, C Atzori, E G I Clementi, M Galli, S Rusconi

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Tenofovir disoproxil fumarate mediates neuronal injury by inducing neurotoxicity.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Homozygous ofFrontiers in genetics · 2021
    Article
  6. Article
  7. Article
  8. Renal Impairment in Chronic Hepatitis B: A Review.Diseases (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

S E SalvaggioInfectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy.
A GiacomelliInfectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy. andrea.giacomelli@unimi.it.
F S FalvellaASST Fatebenefratelli-Sacco, Clinical Pharmacology Department, Milan, Italy.
M L OreniInfectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy.
P MeravigliaASST Fatebenefratelli-Sacco, First Division of Infectious Diseases, Milan, Italy.
C AtzoriASST Fatebenefratelli-Sacco, First Division of Infectious Diseases, Milan, Italy.
E G I ClementiClinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, DIBIC Luigi Sacco - University of Milan, Milan, Italy.
M GalliInfectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy.
S RusconiInfectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy. stefano.rusconi@unimi.it.ORCID 0000-0002-0375-9990
University of Milan · ITASST Fatebenefratelli Sacco · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTenofovir (TDF) is one of the most widely used antiretroviral drug. Despite the high degree of tolerability a small percentage of patients experienced alteration in tubular function during TDF use. Intracellular TDF disposition is regulated by ATP-binding cassette (ABC) drug efflux transporters and, a reduced transport activity may be implicated in accumulation of TDF into the cells. The aim of our study was to assess the major determinants of TDF associated tubular dysfunction (KTD) in a real-life setting including the usefulness of single-nucleotide polymorphisms (SNPs) mapping into ABCC2, ABCC4 and ABCC10 genes.

methodsWe retrospectively analyzed all HIV positive patients who were followed at the Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan from April 2013 to June 2016. All patients treated with TDF who underwent a genotypization for the functional variants mapping in ABCC2 rs717620 (-24 C > T), ABCC4 rs1751034 (3463 A > G) and ABCC10 rs2125739 (T > C) were evaluated. KTD was defined as the presence of urine phosphate wasting and/or proteinuria at 24 h urine analysis.

resultsOne hundred fifty-eight patients were genotyped, of which 42 (26.6%) experienced signs of KTD. No statistical significant differences were observed among patients with or without KTD regarding age, gender, ethnicity and comorbidities (hypertension and diabetes). The percentage of patients with KTD was higher among those with "GG" genotype at rs1751034 of ABCC4 compared to patients without KTD [6 (14.3%) vs 4 (3.5%), p = 0.01]. No statistical significant differences were observed regarding the distribution of ABCC2 and ABCC10 SNPs. Carriers of "G" allele in homozygous status at rs1751034 of ABCC4 showed a significant association with KTD (Odds Ratio 4.67, 95% CI 1.25-17.46, p = 0.02) in bivariate analysis, but this association was lost in multivariable analysis. A significant association between bone diseases and KTD was observed (Odds Ratio 3.178, 95%CI 1.529-6.603, p = 0.002).

conclusionsAccording to our results ABCC4 rs1751034 could be a genetic determinant of KTD; however validation studies are needed for therapy personalization. Noteworthy, a strong association between bone disease and KTD was also observed.

Indexed as

Polymorphism, Single NucleotideAdultAllelesAnti-HIV AgentsATP-Binding Cassette, Sub-Family C ProteinsCohort StudiesFemaleHIV InfectionsHumansKidney DiseasesMaleMiddle AgedMultidrug Resistance-Associated Protein 2ProteinuriaTenofovirABCC10 protein, humanABCC2 protein, humanABCC4 protein, humanAnti-HIV AgentsATP-Binding Cassette, Sub-Family C ProteinsMultidrug Resistance-Associated Protein 2TenofovirHIV-1PharmacogeneticsTenofovir DFTubular dysfunction

Identifiers

PMID28583112
PMCPMC5460416
OpenAlexW2621559411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.